How Much Weight Should I Be Losing on Wegovy?

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, reduces hunger signals in the brain and slows stomach emptying—helping many patients lose weight consistently. However, the exact amount of weight you lose depends on your starting point, adherence, lifestyle factors, and your body's unique biological response to the medication. Understanding realistic expectations helps you stay motivated and recognize whether your treatment plan is working.

Average Weight Loss Timeline on Semaglutide

Clinical trials show that most semaglutide users lose measurable weight within the first 4 weeks of starting treatment. During months 1–3, average weekly loss ranges from 1 to 2 pounds as your body adjusts to the medication and appetite suppression takes effect. By the end of month 3, many patients report losing 5–10 pounds, though individual variation is significant.

Long-term studies tracking patients for 68 weeks found average total weight loss of 15–22% of starting body weight—meaning a 250-pound person might lose 37–55 pounds over the course of treatment. Weight loss plateaus are common around month 4–5; this is normal and does not indicate treatment failure. Continued gradual loss typically resumes as your body stabilizes at a new set point.

Why Your Weight Loss May Differ from Others

Your genetics, metabolism, starting weight, and how closely you follow dietary guidance all influence your individual results. People with obesity and type 2 diabetes often see faster initial weight loss than those with lower starting body mass indexes. Additionally, your genetic predisposition to hunger hormones and fat metabolism pathways affects how your body responds—something PlexusDx's Precision Peptide Genetic Test can reveal.

Physical activity, sleep quality, stress levels, and the number of calories you consume each day work alongside semaglutide to determine your rate of loss. Patients who combine medication with structured eating and movement typically achieve better outcomes than those who rely on the drug alone. Age, hormonal status, and previous weight loss attempts also play roles in determining your success.

Monthly Weight Loss Expectations: What to Track

Month 1–2: Most patients notice reduced appetite and lose 2–8 pounds. Nausea or mild gastrointestinal changes may occur as your body adapts; these usually improve within the first month. Weigh yourself once weekly at the same time of day to spot trends rather than daily fluctuations.

Month 3–6: Weight loss accelerates as your dose increases (if needed for your treatment plan). Average loss during this phase is 1–2 pounds per week. By month 6, cumulative loss often reaches 10–20 pounds. Month 7–12: Loss typically slows to 0.5–1 pound per week as your body reaches a new equilibrium. Total loss by month 12 often ranges from 15–40 pounds depending on your starting weight and adherence.

How PlexusDx Optimizes Your Semaglutide Results

PlexusDx offers compounded semaglutide injections starting at $189/mo (or $149/mo on the 6-month plan) from licensed 503A compounding pharmacies, making personalized GLP-1 therapy accessible without insurance or membership fees. Your medication dose is adjusted based on your response and tolerance—your dose may need to go up, but your price won't change. PlexusDx serves all 50 states and accepts HSA and FSA funds.

For deeper insight into your genetic weight-loss pathways, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment). This test maps 14 metabolic pathways and 49 peptides related to appetite, fat storage, and insulin sensitivity—revealing which genetic variants (such as GIPR rs1800437 and FTO rs9939609) may influence your semaglutide response. This personalization helps your PlexusDx provider fine-tune your treatment plan for maximum effectiveness.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is losing 1–2 pounds per week on semaglutide safe?

Yes, losing 1–2 pounds per week is considered safe and sustainable by major medical organizations. This rate reflects fat loss rather than muscle depletion when combined with adequate protein intake and activity. Faster loss early on typically includes water weight and normalizes over several months.

What if I'm not losing weight after one month on semaglutide?

Some people experience a one- to two-week delay before appetite suppression becomes noticeable. If you've had no weight change by week 4, discuss your dose adjustment, dietary patterns, and medication adherence with your PlexusDx provider. Genetic factors (revealed by the Precision Peptide Genetic Test) may indicate need for an alternative or dual-compound approach like GLP-Squared.

How much does PlexusDx compounded semaglutide cost?

Compounded semaglutide injections start at $189/mo (or $149/mo on the 6-month plan) and remain flat regardless of your dose level. PlexusDx accepts HSA and FSA funds, requires no insurance or membership, and serves all 50 states. Doses are personalized—your price won't increase as your treatment evolves.

Will I regain weight once I stop semaglutide?

Weight regain is possible after discontinuing semaglutide, though not inevitable. Many patients maintain 50–75% of their lost weight long-term through sustained lifestyle changes. Gradual dose reduction under medical supervision (rather than abrupt stopping) may reduce rebound appetite.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), FTO (rs9939609), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Losing Weight
• Glp 1 For Losing Weight
• Zepbound For Losing Weight
• Ozempic For Losing Weight

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.